News

Filter

Current filters:

ActelionVeletri

Japanese approval for Actelion's epoprostenol "ACT"

19-02-2013

Europe's largest biotech firm Actelion (SIX: ATLN) yesterday announced that Japan's Ministry of Health,…

ActelionAsia-PacificBiotechnologyepoprostenol "ACT"RegulationRespiratory and PulmonaryVeletri

FDA approves brand name for Actelion’s PAH drug as Veletri; PAH registry now enrolling patients

26-08-2010

The US subsidiary of Switzerland-based Actelion, Europe’s largest biotechnology firm, says that…

ActelionBiotechnologyNorth AmericaPharmaceuticalRegulationRespiratory and PulmonaryVeletri

COMPANY SPOTLIGHT

Menarini

Back to top